Abstract
Almost ten years ago, standard hemofiltration was often provided at 1 or 2 l/h of ultrafiltration and only in pre-dilution mode. However, practice began to change as results from new studies were published in the early 2000s demonstrating a beneficial effect on outcome of increasing the ultrafiltration rate to 35 ml/kg/h in patients with acute kidney injury (AKI). Two methods of high volume hemofiltration (HVHF), with different underlying concepts and results, became prevalent: Continuous high volume hemofiltration (CHVH) providing 50 to 70 ml/kg/h 24 hours a day, and intermittent high volume hemofiltration (IHVH) with brief, very high volume treatment at 100 to 120 ml/kg/h for 4 to 8 hours (previously called ‘pulse’ HVHF). Two recently published studies [1, 2] highlight the crucial role of adequate dosage of continuous venovenous hemofiltration (CVVH), demonstrating that, in critically ill patients with renal failure, a dose of 35 ml/kg/hour was associated with dramatic improvement in survival of nearly 20 %. The incorporation of the results from these studies into daily clinical practice can now be deemed to be urgent, although the results of other ongoing confirmatory (or not) studies are awaited. In a world increasingly guided by evidence based medicine, two level I studies lead to a Grade A recommendation, and this intervention should, therefore, be applied by every intensivist instigating continuous hemofiltration, while awaiting the results of the ongoing studies. Nevertheless, the implementation process is exposed to a number of potential difficulties. These encompass items such as blood flow requirements, vascular access problems, pre-and post-dilution policy, type of membranes used, as well as restitution fluid and the possible need for associated dialysis. Implementation of these findings will necessitate a collaborative network between medical staff members and the entire nursing staff.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ronco C, Bellomo R, Homel P, et al (2000) Effects of different doses in continuous venovenous haemofiltration. Lancet 356: 26–30
Saudan P, Niederberger M, DeSeigneux S, et al (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70: 1312–1317
Metnitz PG, Krenn CG, Steltzer H, et al (2002) Effects of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30: 2051–2058
Mehta RL, McDonald B, Gabbai FB, et al (2001) Collaborative Group for treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60: 1154–1163
Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138–150
Ronco C, Bellomo R (2002) Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 25: 733–747
Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bellomo R (2003) Interpreting the mechanism of continuous renal replacement therapy in sepsis. The peak concentration hypothesis. Artif Organs 27: 792–801
Ronco C, Ricci Z, Bellomo R (2002) Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role for CVVH. EDTRA ERCA J 2: 13–18
Honore PM, Joannes-Boyau O, Boer W, Gressens B (2007) High volume haemofiltration and hybrid techniques in sepsis: New insights into the rationale. Neth J Crit Care 11: 239–242
Honore PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol 156: 387–395
Di Carlo JV, Alexander SR (2005) Hemofiltration for cytokine-driven illness: the mediator delivery hypothesis. Int J Artif Organs 28: 777–786
Olszewski WL (2003) The lymphatic system in body homeostasis: physiological conditions. Lymphat Res Biol 1: 11–24
Klouche K, Cavadore P, Portales P, Clot J, Canaud B, Beraud JJ (2002) Continuous venovenous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Nephrol 15: 150–157
Seely AJ, Christou NV (2000) Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28: 2193–2200
Mayer J, Rau B, Gansauge F, Beger HG (2000) Inflammatory mediators in human acute pancreatitis: clinical and pathopysiological implications. Gut 47: 542–552
Ertel W, Kremer JP, Kenney J, et al (1995) Down regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85: 1341–1347
Grootendorst AF, vanBommel EF, vander Hoeven B, vanLeengoed LA, vanOsta AL (1992) High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18: 235–240
Grootendorst AF, van Bommel EF, van Leengoed LA, Nabuurs M, Bouman CS, Groeneveld AB (1994) High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2: 72–78
Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL (1999) Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27: 1848–1855
Honoré PM, Zydney AL, Matson JR (2003) High volume and high permeability haemofiltration in sepsis. The evidences and the key issues. Care Crit Ill 3: 69–76
Journois D, Israel-Biet D, Pouard P, et al (1996) High volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85: 965–976
Honoré PM, Jamez J, Wauthier M, et al (2000) Prospective evaluation of short term high volume isovolemic haemofiltration on the haemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 3581–3587
Honoré PM, Joannes-Boyau O (2004) High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 27: 1077–1082
Matson JR, Zydney RL, Honoré PM (2004) Blood filtration: New opportunities and the implications on system biology. Crit Care Resusc;6: 209–218
Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25: 814–821
Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978–986
Cornejo R, Downey P, Castro R, et al (2006) High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32: 713–722
Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50: 102–109
Piccinni P, Dan M, Barbacini S, et al (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32: 80–86
Ratanarat R, Brendolan A, Piccinni P, et al (2005) Pulse-high volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9: 294–302
Bouman CS, Oudemans-Van-Straaten HM, Tijssen JG, Zandstra DF, Kosecioglu J (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30: 2205–2211
Wang H, Zhang ZH, Yan XW, et al (2005)Amelioration of haemodynamics an oxygen metabolism by continuous veno venous hemofiltration in experimental pancreatitis. Word J Gastroenterol 11: 127–131
Wang H, Li WQ, Zhou W, Li N, Li JS (2003) Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 9: 2096–2099
Jiang HL, Xhue WJ, Li DK, et al (2005) Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 11: 4815–4821
Palevsky PM, Zhang JH, O’Connor TZ, et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20
Ronco C, Honore PM (2008) Renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 1959
Ronco C, Cruz D, Oudemans-van-Straaten HM, Honoré PM, House A, Bin D, Gibney N (2008) Dialysis dose in acute kidney injury: no time for therapeutic nihilism-a critical appraisal of the Acute Renal Failure Trial Network study. Crit Care 12: 308
Li CM, Chen JH, Zhang P, et al (2007) Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 35: 911–919
Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E (2001) Factors influencing permanent catheter performance. J Vasc Access 2: 106–109
Ricci Z, Ronco C (2005) Preversus post-dilution CVVH. Blood Purif 23: 338–342
Nurmohamed SA, Vervloet MG, Girbes AR, Ter Wee PM, Groeneveld AB (2007) Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study. Blood Purif 25: 316–323
Ratanarat R, Cazzavillan S, Ricci Z, et al (2007) Usefulness of a molecular strategy for the detection of bacterial DNA in patients with severe sepsis undergoing continuous renal replacement therapy. Blood Purif 25: 106–111
Arzuaga A, Isla A, Gascon AR, Maynar J, Corral E, Pedraz JL (2006) Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient. Blood Purif 24: 347–354
Kooman JP, van der Sande FM, Beerenhout CM, Leunissen KM (2006) On-line filtration therapies: emerging horizons. Blood Purif 24: 159–162
Bellomo R, Honoré PM, Matson JR, Ronco C, Winchester J (2005) Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Consensus statement. Position paper. ADQI III Conference. Int J Artif Organs 28: 450–458
Bellomo R, Kellum JA, Mehta R, Ronco C (2002) The Acute Dialysis Quality Initiative II: the Vicenza conference. Adv Ren Replace Ther 9 290–293
Tetta C, Bellomo R, Kellum J, et al (2004) High volume hemofiltration in critically ill patients: why, when and how? Contrib Nephrol 144: 362–375
Honore PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: High-volume hemofiltration-A global view. Contrib Nephrol 156: 371–386
Honore PM, Joannes-Boyau O, Meurson L, et al (2006) The Big Bang of haemofiltration: the beginning of a new era in the third Millennium for extra-corporeal blood purification! Int J Artif Organs 2006 29: 649–659
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Honoré, P.M., Joannes-Boyau, O., Boer, W. (2009). High-flow Hemofiltration as an Adjunctive Therapy in Sepsis. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2009. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-92276-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-540-92276-6_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-92275-9
Online ISBN: 978-3-540-92276-6
eBook Packages: MedicineMedicine (R0)